Open-House-Biologika-Rabattverträge 2025-19 - Adalimumab
openRead the notice at vergabe-de ↗
Value
unstated
Published
17 Nov 2026
Deadline
31 Dec 2026, 22:58 GMT · 40d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600
Description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Adalimumab im Rahmen eines Open-House-Verfahrens.
Key facts
- Reference
- OB-2025-19
- Procedure
- open
- Lots
- 1
- Contact
- DZEM@tk.de+49 4069094-040
- Bids opened
- 31 Dec 2026, 22:59 GMT
- Regime
- publicSector
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- vergabe-de
- Notice id
- dce5ee6d-bd50-4aa2-9ac6-c73316e1c3fd
- OCID
- ocds-mnwr74-30a7d19c-5428-4233-9885-fbd4694eb3f5
- First seen
- 22 Nov 2026
- Last updated
- 22 Nov 2026
Licence CC0 1.0 public domain dedication ↗
Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.
View at source ↗
GET /api/v1/tenders/9c4cedce-0362-4ea8-9ce2-5fbaefe8ef3cThe source notice is authoritative — verify deadlines and documents there before bidding.